Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease
Clinical trial NCT05292950 · TERMINATED
Trial details
- NCT number
- NCT05292950
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-27
- Primary completion
- 2024-11-12
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.